OBA-PHARMA ApS: Financial statements 2017
CVR: 19995607
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,770,857 and a net result of DKK 2,155,159 compared with DKK 2,206,997 the year before. That is a decrease of 1.4% compared with the year before. Equity in the 2017 report amounted to DKK 4,428,544. The solvency ratio was 66.1%.
- Gross Profit
- DKK 2,770,857
- Profit/Loss
- DKK 2,155,159
- Equity
- DKK 4,428,544
- Total Assets
- DKK 6,698,747
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 2.8 mio. | 2.2 mio. | 4.4 mio. | - |
| 2016 | - | 2.8 mio. | 2.2 mio. | 2.8 mio. | - |
| 2015 | - | 3.2 mio. | 2.5 mio. | 3.1 mio. | - |
| 2014 | - | 3.7 mio. | 3.1 mio. | 3.6 mio. | - |
| 2013 | - | 2.9 mio. | 2.4 mio. | 3 mio. | - |
Official annual report
Keep an eye on OBA-PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
OBA-PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 2,809,440, and the net result was DKK 2,206,997.
As of February 3, 2017, BHA STATSAUTORISERET REVISION APS has been appointed auditor of OBA-PHARMA ApS.
About OBA-PHARMA ApS
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees (2000). In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity in the 2024 report amounted to DKK 674,251.